Today's Top Stories


Hot Topics


Comment & Analysis »

GlobalData Healthcare

GSK’s Shingrix set to disrupt the herpes zoster vaccine marketplace

On September 13, GlaxoSmithKline announced that the FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend the approval of its investigational...

GSK’s Shingrix set to disrupt the herpes zoster vaccine marketplace
GlobalData Healthcare

UCB’s latest anti-epileptic drug advances in the epilepsy market

UCB’s latest anti-epileptic drug advances in the epilepsy market
GlobalData Healthcare

Nabriva’s first-in-class antibiotic lefamulin aces key Phase III test

Nabriva’s first-in-class antibiotic lefamulin aces key Phase III test
GlobalData Healthcare

Failure of first lampalizumab Phase III study could delay availability

Failure of first lampalizumab Phase III study could delay availability
GlobalData Healthcare

ESMO 2017: PD-L1 as an Evolving Narrative in Patient Selection and Drug Resistance – Part 2

ESMO 2017: PD-L1 as an Evolving Narrative in Patient Selection and Drug Resistance – Part 2

Company Releases »

Sartorius Lab Instrument's Cubis® Balance Range Meets the Cleanability Requirements of the Pharmaceutical Industry

Sartorius
Sartorius Lab Instrument's Cubis® Balance Range Meets the Cleanability Requirements of the Pharmaceutical Industry

From Gene to Finished Vial

Biovian
From Gene to Finished Vial

Softigel by Procaps Brochure

Softigel Softigel by Procaps Brochure

The ImmunoPrecise Rapid Prime System Reduces the Immunization Stage of Hybridoma Production to 18 Days

ImmunoPrecise Antibodies
The ImmunoPrecise Rapid Prime System Reduces the Immunization Stage of Hybridoma Production to 18 Days

Biopharmaceutical Laboratory Equipment and Integrated Bioprocess Services

Sartorius Biopharmaceutical Laboratory Equipment and Integrated Bioprocess Services

Drugdevelopment Insights »

Drugdevelopment Industry Reports »

Report: Immuno-Oncology to evolve as promising cancer treatment alternative

Report: Immuno-Oncology to evolve as promising cancer treatment alternative

Osteoarthritis is significantly underdiagnosed in the US

Osteoarthritis is significantly underdiagnosed in the US

Immuno-Oncology drugs lead Japanese clinical trials, 2012-2016

Immuno-Oncology drugs lead Japanese clinical trials, 2012-2016

PAH registries may underestimate patient size by as much as sevenfold

PAH registries may underestimate patient size by as much as sevenfold








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115